LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-13. Numbers and descriptions here follow the published literature rather than marketing material.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
Some clinical tests require clinical chemists to process the specimen before testing. Clinical chemists and medical laboratory scientists serve as the interface between the laboratory side and the clinical practice, providing suggestions to physicians on which test panel to order and interpret any irregularities in test results that reflect on the patient's health status and organ system functionality. This allows healthcare providers to make more accurate evaluation of a patient's health and to diagnose disease, predicting the progression of a disease (prognosis), screening, and monitoring the treatment's efficiency in a timely manner. The type of test required dictates what type of sample is used.
The biopolymers that comprise DNA, RNA, and (poly)peptides are linear heteropolymers (i.e.: each monomer is connected to at most two other monomers). The sequences of their monomers effectively encodes information. The transfers of information from one molecule to another are faithful, deterministic transfers, wherein one biopolymer's sequence is used as a template for the construction of another biopolymer with a sequence that is entirely dependent on the original biopolymer's sequence. When DNA is transcribed to RNA, its complement is paired to it. DNA codes are transferred to RNA codes in a complementary fashion. The encoding of proteins is done in groups of three, known as codons. The standard codon table applies for humans and mammals, but some other lifeforms (including human mitochondria) use different translations.
Tyrannosaurus is the type genus of the superfamily Tyrannosauroidea, the family Tyrannosauridae, and the subfamily Tyrannosaurinae; in other words it is the standard by which paleontologists decide whether to include other species in the group. Other members of the tyrannosaurine subfamily include the North American Daspletosaurus and the Asian Tarbosaurus, both of which have occasionally been synonymized with Tyrannosaurus. Tyrannosaurids were once commonly thought to be descendants of earlier large theropods such as megalosaurs and carnosaurs, although more recently they were reclassified with the generally smaller coelurosaurs. The earliest tyrannosaur group were the crested proceratosaurids, while later and more derived members belong to the Pantyrannosauria. Tyrannosaurs started out as small theropods; at least some became larger by the Early Cretaceous. It is likely that tyrannosauroids rose to prominence after the decline in allosauroid and megalosauroid diversity seen during the early stages of the Late Cretaceous. Tyrannosauroids are characterized by their fused nasals and dental arrangement. Pantyrannosaurs are characterized by unique features in their hips as well as an enlarged foramen in the quadrate, a broad postorbital and hourglass shaped nasals. Some of the more derived pantyrannosaurs lack nasal pneumaticity and have a lower humerus to femur ratio with their arms starting to see some reduction. Some pantyrannosaurs started developing an arctometatarsus.
== Uses == Putrescine reacts with adipic acid to yield the polyamide nylon 46, which is marketed by Envalior (formerly DSM) under the trade name Stanyl. Due to its role in putrification, putrescine has also been proposed as a biochemical marker for determining how long a corpse has been decomposing.
=== Sources === Grant, Michael (1993). The History of Rome. Faber and Faber. ISBN 0-571-11461-X. Lane Fox, Robin (2005). The Classical World. Penguin Books. ISBN 0-14-102141-1. Matyszak, Philip (2004). The Enemies of Rome. New York: Thames and Hudson. ISBN 0-500-25124-X. Musti, Domenico (1990). "La spinta verso il Sud: espansione romana e rapporti "internazionali"". Storia di Roma. Vol. I. Turin: Einaudi. ISBN 978-88-06-11741-2.
Sources: en.wikipedia.org
== Relationship with Eucalyptus Health == Juniper is part of Eucalyptus Health's portfolio of healthcare brands, alongside Pilot, Kin, Software and Compound. By 2025, the United Kingdom had become Eucalyptus Health's largest market. During this time, there was a period of medication shortage (notably Ozempic) so Eucalyptus temporarily paused new Juniper memberships in the UK to prioritise supply for existing patients, resuming uptake once supply constraints eased. In March 2025, Eucalyptus generated approximately A$200 million in revenue over the preceding 18 months from weight-loss services and medications across its brands, with revenue rising 55 per cent year-on-year to A$120.9 million. This growth aligned with improved supply of GLP-1 medications alongside the company's expansion in several international markets. In May 2025, Eucalyptus entered early discussions for an A$100–150 million funding round, positioning the company for a valuation exceeding A$1 billion (unicorn status). Eucalyptus became one of Australia's largest online weight-loss medication providers and its growth attracted both investor interest and regulatory scrutiny.
=== Source and biosynthesis === Valine, like other branched-chain amino acids, is synthesized by bacteria and plants, but not by animals. It is therefore an essential amino acid in animals, and needs to be present in the diet. Adult humans require about 24 mg/kg body weight daily. It is synthesized in plants and bacteria via several steps starting from pyruvic acid. The initial part of the pathway also leads to leucine. The intermediate α-ketoisovalerate undergoes reductive amination with glutamate. Enzymes involved in this biosynthesis include:
This similarity suggests that the two enzymes originally arose due to gene duplication, and evolved over time to fill unique roles in the coagulation cascade. Clotting enzymes isolated from Limulus polyphemus and Tachypleus tridentatus exhibit similar properties, indicating high conservation of this enzyme throughout evolutionary divergence.
Most octopuses swim by expelling a jet of water from the mantle through the siphon into the sea. The direction of travel depends on the orientation of the siphon. When swimming, the head is at the front and the siphon is pointed backward but, when jetting, the visceral hump leads, the siphon points at the head and the arms trail behind, with the animal presenting a fusiform appearance. In an alternative method of swimming, some species flatten themselves dorso-ventrally, and swim with the arms splayed; this may provide lift and be faster than normal swimming. Jetting is used to escape from danger, but is physiologically inefficient, requiring a mantle pressure so high as to stop the heart from beating, resulting in a progressive oxygen deficit. Cirrate octopuses cannot produce jet propulsion and swim using their fins. Their neutrally buoyant bodies float along while the fins are spread. They can also contract their arms and surrounding web to make sudden moves known as "take-offs". Another form of locomotion is "pumping", which involves symmetrical contractions of muscles in their webs producing peristaltic waves, moving them slowly.
Desglymidodrine (developmental code name ST-1059) is the active metabolite of the prodrug antihypotensive agent midodrine. It acts as a selective α1-adrenergic receptor agonist. Desglymidodrine is formed from midodrine via deglycination.
Sources: en.wikipedia.org
==== National League runs scored record (2000) ==== In a presentation of rankings of active major leaguers prior to the 2000 season, Sports Illustrated slotted Bagwell second among position players behind Ken Griffey Jr., and The Sporting News placed him sixth among all players, including pitchers. Bagwell christened the team's 2000 move to Enron Field (later renamed Minute Maid Park) with the stadium's first-ever hit and first two runs driven in, in a 6–5 exhibition victory over the New York Yankees on March 30. His two-run, ninth-inning home run against Trevor Hoffman in San Diego on June 10 won the contest for Houston, 7–6, and stopped a 10-game road losing streak. On August 14 in Philadelphia, he homered twice and tied a club record with seven RBI in a 14–7 win, shared by Rafael Ramírez and Pete Incaviglia. Five days later against Milwaukee, Bagwell again homered twice for the 299th and 300th of his career; the second home run broke an eighth-inning tie to give Houston a 10–8 win. He joined Hank Aaron, Joe DiMaggio, Frank Robinson and Ted Williams as the fifth player in major league history to record 300 home runs, 1,000 RBI and 1,000 runs scored in his first ten seasons. Bagwell finished the 2000 season with a career-high 47 home runs, .310 average, .424 OBP, .615 SLG (the second-best mark of his career) for a 152 OPS+. His 152 runs scored was the highest total in a season since Lou Gehrig in 1936, and his 295 runs scored from 1999 to 2000 set a National League two-season record.
In November 1953, Florey was informed that works would proceed as planned. On 27 March 1958, Florey ceremoniously opened the John Curtin School of Medical Research and received an honorary Doctor of Science degree along with Sir Norman Gregg. Menzies, Coombes, Ennor and Curtin's family were in attendance. This was not the end of Florey's association with the ANU. In 1964, he accepted the role of chancellor, a position he held from 1965 until his death in 1968.
The basic equation of radiometric dating requires that neither the parent nuclide nor the daughter product can enter or leave the material after its formation. The possible confounding effects of contamination of parent and daughter isotopes have to be considered, as do the effects of any loss or gain of such isotopes since the sample was created. It is therefore essential to have as much information as possible about the material being dated and to check for possible signs of alteration. Precision is enhanced if measurements are taken on multiple samples from different locations of the rock body. Alternatively, if several different minerals can be dated from the same sample and are assumed to be formed by the same event and were in equilibrium with the reservoir when they formed, they should form an isochron. This can reduce the problem of contamination. In uranium–lead dating, the concordia diagram is used which also decreases the problem of nuclide loss. Finally, correlation between different isotopic dating methods may be required to confirm the age of a sample. For example, the age of the Amitsoq gneisses from western Greenland was determined to be 3.60 ± 0.05 Ga (billion years ago) using uranium–lead dating and 3.56 ± 0.10 Ga (billion years ago) using lead–lead dating, results that are consistent with each other.
== Function == Arginase catalyzes the hydrolysis of arginine to ornithine and urea. In addition to arginase-1, there also exists a second type arginase-2, which differs in its tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. Two transcript variants encoding different isoforms have been found for this gene.
The revived Mannerist sphinx of the late 15th century is sometimes thought of as the "French sphinx". Her coiffed head is erect and she has the breasts of a young woman. Often she wears ear drops and pearls as ornaments. Her body is naturalistically rendered as a recumbent lioness. Such sphinxes were revived when the grottesche or "grotesque" decorations of the unearthed Domus Aurea of Nero were brought to light in late 15th-century Rome, and she was incorporated into the classical vocabulary of arabesque designs that spread throughout Europe in engravings during the 16th and 17th centuries. Sphinxes were included in the decoration of the loggia of the Vatican Palace by the workshop of Raphael (1515–20), which updated the vocabulary of the Roman grottesche. The first appearances of sphinxes in French art are in the School of Fontainebleau in the 1520s and 1530s and she continues into the Late Baroque style of the French Régence (1715–1723). From France, she spread throughout Europe, becoming a regular feature of the outdoors decorative sculpture of 18th-century palace gardens, as in the Upper Belvedere Palace in Vienna, Sanssouci Park in Potsdam, La Granja in Spain, Branicki Palace in Białystok, or the late Rococo examples in the grounds of the Portuguese Queluz National Palace (of perhaps the 1760s), with ruffs and clothed chests ending with a little cape.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.